Annual EBITDA
$6.82B$707.00M+11.57%
Summary
- Current Value
- As of today, SYK annual EBITDA is $6.82B, up +11.57% on
- Historical Performance
- SYK annual EBITDA is up +44.08% over the past 3 years, up +81.28% over the past 5 years
- All-Time High Comparison
- SYK annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- SYK annual EBITDA is +44.08% above its 3-year low of $4.73B reached on an earlier date
- Sector Comparison
- SYK annual EBITDA is higher than 98.07% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $6.82B | +11.6% | +44.1% | +81.3% | +201.6% | |
| Quarterly EBITDA | $2.08B | +25.3% | +56.9% | +76.2% | +291.5% | |
| TTM EBITDA | $7.46B | +14.3% | +49.6% | +61.5% | +231.5% | |
| Price | $345.81 | -8.2% | +22.6% | +34.3% | +626.8% | |
| PE Ratio | 35.83 | -28.1% | -10.1% | -24.0% | +137.9% | |
| Annual Revenue | $25.12B | +11.2% | +36.1% | +75.0% | +243.1% | |
| Annual EPS | $8.40 | +8.2% | +36.1% | +99.7% | +163.3% | |
| Annual EBIT | $5.63B | +11.1% | +50.6% | +90.7% | +204.0% | |
| Annual Net Income | $3.25B | +8.4% | +37.7% | +103.0% | +154.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $6.82B | at high | |
| 5Y | $6.82B | at high | |
| All | $6.82B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.73B | N/A | +44.1% |
| 5Y | $3.76B | N/A | +81.3% |
| All | $5.89M | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of SYK?
- As of today, SYK annual EBITDA is $6.82B
- What is 1-year change in SYK annual EBITDA?
- SYK annual EBITDA is up +11.57% year-over-year
- What is 3-year change in SYK annual EBITDA?
- SYK annual EBITDA is up +44.08% over the past 3 years
- How far is SYK annual EBITDA from its all-time high?
- SYK annual EBITDA is currently at its all-time high
- How does SYK annual EBITDA rank versus sector peers?
- SYK annual EBITDA is higher than 98.07% of companies in Healthcare sector
- When is SYK next annual earnings release?
- As of today, the next annual earnings release for SYK has not been scheduled
EBITDA Formula
Quarterly EBITDA
$2.08B$672.00M+47.86%
Summary
- Current Value
- As of today, SYK quarterly EBITDA is $2.08B, up +47.86% on
- Historical Performance
- SYK quarterly EBITDA is up +25.29% year-over-year, up +56.92% over the past 3 years
- All-Time High Comparison
- SYK quarterly EBITDA is currently -9.93% below its historical high of $2.31B set on
- 3-Year Low Comparison
- SYK quarterly EBITDA is +65.68% above its 3-year low of $1.25B reached on
- Sector Comparison
- SYK quarterly EBITDA is higher than 98.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $2.08B | +47.9% | +25.3% | +56.9% | +76.2% | |
| Annual EBITDA | $6.82B | – | +11.6% | +44.1% | +81.3% | |
| TTM EBITDA | $7.46B | +6.0% | +14.3% | +49.6% | +61.5% | |
| Price | $345.81 | +22.4% | -8.2% | +22.6% | +34.3% | |
| PE Ratio | 35.83 | +9.5% | -28.1% | -10.1% | -24.0% | |
| Quarterly Revenue | $6.59B | +9.4% | +9.4% | +31.9% | +53.5% | |
| Quarterly EPS | $3.31 | +71.5% | +44.5% | +72.0% | +113.5% | |
| Quarterly EBIT | $1.78B | +61.2% | +30.8% | +67.3% | +90.0% | |
| Quarterly Net Income | $1.28B | +71.3% | +44.3% | +72.9% | +115.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.31B | -9.9% | |
| 3Y | $2.31B | -9.9% | |
| 5Y | $2.31B | -9.9% | |
| All | $2.31B | -9.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.40B | +47.9% | |
| 3Y | $1.25B | +65.7% | |
| 5Y | $1.03B | +102.3% | |
| All | -$104.50M | +2086.6% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of SYK?
- As of today, SYK quarterly EBITDA is $2.08B
- What is SYK quarterly EBITDA most recent change?
- SYK quarterly EBITDA was up +47.86% on June 30, 2026
- What is 1-year change in SYK quarterly EBITDA?
- SYK quarterly EBITDA is up +25.29% year-over-year
- How far is SYK quarterly EBITDA from its all-time high?
- SYK quarterly EBITDA is currently -9.93% below its historical high of $2.31B set on December 31, 2025
- How does SYK quarterly EBITDA rank versus sector peers?
- SYK quarterly EBITDA is higher than 98.10% of companies in Healthcare sector
- When is SYK next earnings release?
- The next earnings release for SYK is on
EBITDA Formula
TTM EBITDA
$7.46B$419.00M+5.95%
Summary
- Current Value
- As of today, SYK TTM EBITDA is $7.46B, up +5.95% on
- Historical Performance
- SYK TTM EBITDA is up +14.28% year-over-year, up +49.61% over the past 3 years
- All-Time High Comparison
- SYK TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- SYK TTM EBITDA is +49.61% above its 3-year low of $4.99B reached on an earlier date
- Sector Comparison
- SYK TTM EBITDA is higher than 97.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $7.46B | +6.0% | +14.3% | +49.6% | +61.5% | |
| Annual EBITDA | $6.82B | – | +11.6% | +44.1% | +81.3% | |
| Quarterly EBITDA | $2.08B | +47.9% | +25.3% | +56.9% | +76.2% | |
| Price | $345.81 | +22.4% | -8.2% | +22.6% | +34.3% | |
| PE Ratio | 35.83 | +9.5% | -28.1% | -10.1% | -24.0% | |
| TTM Revenue | $25.84B | +2.2% | +8.5% | +32.8% | +59.0% | |
| TTM EPS | $9.65 | +11.8% | +27.7% | +36.4% | +76.7% | |
| TTM EBIT | $6.24B | +7.2% | +14.9% | +57.3% | +69.5% | |
| TTM Net Income | $3.73B | +11.8% | +27.8% | +37.6% | +79.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.46B | at high | |
| 3Y | $7.46B | at high | |
| 5Y | $7.46B | at high | |
| All | $7.46B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.53B | N/A | +14.3% |
| 3Y | $4.99B | N/A | +49.6% |
| 5Y | $4.61B | +61.7% | |
| All | -$32.20M | >+9999.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of SYK?
- As of today, SYK TTM EBITDA is $7.46B
- What is SYK TTM EBITDA most recent change?
- SYK TTM EBITDA was up +5.95% on June 30, 2026
- What is 1-year change in SYK TTM EBITDA?
- SYK TTM EBITDA is up +14.28% year-over-year
- How far is SYK TTM EBITDA from its all-time high?
- SYK TTM EBITDA is currently at its all-time high
- How does SYK TTM EBITDA rank versus sector peers?
- SYK TTM EBITDA is higher than 97.90% of companies in Healthcare sector
- When is SYK next earnings release?
- The next earnings release for SYK is on
EBITDA Formula
Data Sources & References
- SYK Official Website www.stryker.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/310764/000031076426000006/0000310764-26-000006-index.htm
- SYK Profile on Yahoo Finance finance.yahoo.com/quote/SYK
- SYK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/syk
